FAC MEDICINA
Centro
Linköping University
Linköping, SueciaPublicaciones en colaboración con investigadores/as de Linköping University (16)
2024
-
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Gut, Vol. 73, Núm. 5, pp. 825-834
2023
-
Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol
Contemporary Clinical Trials, Vol. 134
-
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements
Clinical Kidney Journal, Vol. 16, Núm. 4, pp. 735-744
2020
-
Circulating Dendritic Cells from Celiac Disease Patients Display a Gut-Homing Profile and are Differentially Modulated by Different Gliadin-Derived Peptides
Molecular Nutrition and Food Research, Vol. 64, Núm. 6
-
Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in ESKD patients
International Journal of Molecular Sciences, Vol. 21, Núm. 4
-
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Contemporary Clinical Trials, Vol. 98
2019
2018
-
The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis
British Journal of Anaesthesia, Vol. 120, Núm. 1, pp. 146-155
2015
-
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
JAMA - Journal of the American Medical Association, Vol. 313, Núm. 13, pp. 1347-1361
2013
2012
-
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Human Mutation, Vol. 33, Núm. 4, pp. 690-702
2011
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754
2007
-
Nup88 expression in normal mucosa, adenoma, primary adenocarcinoma and lymph node metastasis in the colorectum
Tumor Biology, Vol. 28, Núm. 2, pp. 93-99
2003
-
Clinicopathological significance of Nup88 expression in patients with colorectal cancer
Oncology, Vol. 64, Núm. 4, pp. 361-369
2002
-
Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells.
International journal of oncology, Vol. 21, Núm. 1, pp. 43-48